Issues Archive

The most complete archive of clinical and pathology lab industry news available, including issues from 1997 to the present.

Volume XXV No. 17 – December 3, 2018

In this issue:

DID CONGRESS JUST PASS A LAW that makes innocent labs guilty of criminal acts? At the last minute, Congress added all clinical laboratories to a far-reaching anti-kickback provision in the newly-enacted Support for Patients and Communities Act — a provision that makes common practices such as paying commissions to sales staff or placing phlebotomists in labs could be illegal. Worse: The experts are baffled by the language of the new law. Notes one of these experts in this issue, “Someone in the clinical lab industry may have to get prosecuted before we get some clarity, unless the Secretary of HHS issues clarifying regulations.”

View Issue TOC

Volume XXV No. 16 – November 13, 2018

In this issue:

THE DARK REPORT ANALYZES a change of heart by the federal Centers for Medicare and Medicaid Services in the way it will collect data about the lab test prices paid by private health insurers. Good news? Not so fast. The changes CMS calls for won’t impact the Medicare fee schedule for two years. But on Jan. 1, 2019, CMS will make another painful 10% cut in what it pays for lab tests. Also in this issue is an exclusive look at how an innovative commercial lab company is developing ways to collaborate with physicians, health insurers, ACOs and others to improve patient care and lower the cost of care—and be paid for those contributions.

View Issue TOC

Volume XXV No. 15 – October 22, 2018

In this issue:

WHO WILL BE NEXT? As federal prosecutors indicate in court there’s more to come in the ongoing Theranos investigation, that leaves the lab industry wondering who else might be charged with crimes. Reported only in THE DARK REPORT, this development means that any number of people could be targeted: former members of the Board of Directors, various consultants, even vendors. Meanwhile, Medicare has begun publicly posting prices charged by every pathologist in the country — so that every one of them can find out what their competition is up to. Will a new price war result? THE DARK REPORT offers a pricing “sweet spot” for readers to consider.

View Issue TOC

Volume XXV No. 14 – October 1, 2018

In this issue:

TWO FEDERAL COURT RULINGS that will have immediate impact on the clinical lab industry are analyzed in detail in this issue. In a major setback for the ACLA lawsuit against the federal Department of Health and Human Services, a judge has ruled that the court lacks jurisdiction to take the case. THE DARK REPORT also offers an exclusive interview with the ACLA’s lead attorney to help readers understand the issues surrounding a possible appeal. Also exclusive to THE DARK REPORT is a report about a court ruling that two fairly common lab business practices are illegal inducements.

View Issue TOC

Volume XXV No. 13 – September 10, 2018

In this issue:

CLINICAL LABORATORY MANAGERS will learn in this issue about two trends that are driving a movement to standardize laboratory operations across large regions: the integration of clinical care and the need for hospitals and health networks to improve patient outcomes continuously. THE DARK REPORT dives deeply into the details of an ambitious program along these lines in Michigan. Also, Theranos’ dying breath is detailed as the once-vaunted company finally goes under.

View Issue TOC

Volume XXV No. 12 – August 20, 2018

In this issue:

THE DARK REPORT HAS UNCOVERED a previously unnoticed trend that turns common wisdom on Wall Street upside down: Hospitals and health systems may be taking back control of their their laboratory outreach programs instead of selling them, and committing major resources to their inpatient labs instead of outsourcing their management. TDR is the first to analyze this trend in three separate articles. Also, for both anatomical and clinical pathology, value-based payment is coming, creating an opening for pathologists who move quickly.

View Issue TOC

Volume XXV No. 11 – July 30, 2018

In this issue:

THE DARK REPORT DEMONSTRATES that CMS is once again seemingly ignoring Congress’ intent with the Protecting Access to Medicare Act (PAMA) by leaving out hospital labs and outreach laboratories from price reporting. What will the outcome be this time around? Also, only TDR has detected a potential opportunity in managed care contracting for regional and outreach labs that can demonstrate how they add value to patient care.

View Issue TOC

Volume XXV No. 10 – July 9, 2018

In this issue:

A CRISIS IN IRELAND has put two American laboratories in the crosshairs of potentially disastrous news reports, which, as THE DARK REPORT demonstrates, can quickly undermine the credibility – and profitability – of any lab. Also, THE DARK REPORT is first in the industry to call attention to new developments in the lab testing marketplace that have the potential to influence all clinical labs and pathology groups – in this case, the decision by two innovative health networks to make genetic tests available to their patients at primary care clinics.

View Issue TOC

Volume XXV No. 9 – June 18, 2018

In this issue:

THE DARK REPORT sums up a tale of two fraudsters: Two counts of conspiracy, nine counts of wire fraud, the possibility of a lifetime in prison and $2.75M in fines each for Theranos’ Elizabeth Holmes and Ramesh “Sunny” Balwani. What does it all mean for tech startups – and clinical labs? Also, this issue delivers specific strategies that lab outreach directors can use to overcome current challenges and protect revenue, increase market share, and contribute to better patient care.

View Issue TOC

Volume XXV No. 8 – May 29, 2018

In this issue:

THE DARK REPORT HAS DISCOVERED an intriguing but quiet trend in recent months: Lab companies are suddenly snatching up struggling rural hospitals to take advantage of their higher payment rates in what is called “pass-through billing,” a process that can and has strayed over the line into illegal territory. Interestingly, the businessman involved in one such recent transaction insists he “ran away as fast as possible” from an earlier company that was engaged in some sketchy billing schemes. Also in this issue, John Carreyrou of The Wall Street Journal describes his shocking experiences as he dug into, and later exposed, the now-infamous Theranos pyramid scheme.

View Issue TOC

Don’t Be at the Mercy of the Tumultuous Healthcare Revolution

Subscribe to The Dark Report for as little as $15.27 per week.

The Dark Report

Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.

		
Get digital and print editions of The Dark Report for only $22.97 per week. Plus a Free bonus Executive Briefing
Get web access of The Dark Report for only $19.12 per week. Plus a Free bonus Executive Briefing
Get a hard copy of The Dark Report delivered to your home for only $15.27 per week. Plus a Free bonus Executive Briefing
Enter Your Login Credentials
This setting should only be used on your home or work computer.

×